| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Options Exercise | $346,373 | +8,127 | +37% | $42.62 | 30,035 | 24 Feb 2025 | Direct | |
| transaction | MEDP | Common Stock | Sale | $1,383,397 | -4,003 | -13% | $345.59 | 26,032 | 24 Feb 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Stock Option (Right to Buy) | Options Exercise | $0 | -8,127 | -100% | $0.000000 | 0 | 24 Feb 2025 | Common Stock | 8,127 | $42.62 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $344.798 to $346.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F2 | The option vested in full on May 16, 2019. |